• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮下肢动脉介入治疗中,单纯球囊扩张与 Silverhawk 旋切术联合球囊扩张的随机试验。

Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial.

机构信息

Midwest Cardiovascular Research Foundation, Davenport, IA 52803, USA.

出版信息

J Vasc Interv Radiol. 2011 Sep;22(9):1223-8. doi: 10.1016/j.jvir.2011.05.013. Epub 2011 Jul 14.

DOI:10.1016/j.jvir.2011.05.013
PMID:21757372
Abstract

PURPOSE

Target lesion revascularization (TLR) with primary percutaneous transluminal angioplasty (PTA) versus SilverHawk atherectomy and adjunctive PTA of de novo infrainguinal disease has not been well defined. This study was conducted to compare the two approaches.

MATERIALS AND METHODS

In this prospective, two-center randomized trial of PTA versus atherectomy of infrainguinal vessels, the primary endpoint of TLR was evaluated at 1 year. Secondary endpoints included the rate of "bailout" stent placement for suboptimal acute angiographic results and the rate of target vessel revascularization (TVR).

RESULTS

Fifty-eight patients were included in the study. Of these, 29 (36 vessels) were randomized to the atherectomy arm and 29 (48 vessels) to the PTA arm. Final acute angiographic success rates were 100% in the PTA arm and 97.2% in the atherectomy arm (P value not significant). There was no statistical difference in TLR (16.7% vs 11.1%) or TVR (21.4% vs 11.1%) between the PTA and atherectomy groups, respectively. Bailout stent placement was performed in 18 of 29 patients (62.1%) in the PTA arm and eight of 29 patients (27.6%) in the atherectomy arm (P = .017). Major adverse events were similar between the PTA and atherectomy arms. Finally, when embolic filter protection was used, distal macroembolization occurred in 11 of 17 patients (64.7%) treated with atherectomy versus none of 10 in the PTA group (P < .001).

CONCLUSIONS

TLR and TVR at 1 year were statistically similar in atherectomy and primary PTA. Atherectomy reduced the need for bailout stent placement compared with primary PTA.

摘要

目的

在初次经皮腔内血管成形术(PTA)与 SilverHawk 旋切术和辅助 PTA 治疗新发下肢动脉疾病中,靶病变血运重建(TLR)的效果尚未明确。本研究旨在比较这两种方法。

材料和方法

在这项前瞻性、两中心随机试验中,比较了 PTA 与旋切术治疗下肢动脉疾病,主要终点是 1 年时的 TLR。次要终点包括因急性血管造影结果不理想而进行补救性支架置入的比例和靶血管血运重建(TVR)的比例。

结果

本研究共纳入 58 例患者(共 68 支血管),其中 29 例(36 支血管)随机分入旋切术组,29 例(48 支血管)分入 PTA 组。PTA 组的最终急性血管造影成功率为 100%,旋切术组为 97.2%(P 值无统计学意义)。两组间 TLR(16.7%比 11.1%)或 TVR(21.4%比 11.1%)无统计学差异。PTA 组中有 18 例(62.1%)患者需要补救性支架置入,旋切术组中有 8 例(27.6%)患者需要补救性支架置入(P=0.017)。PTA 组和旋切术组的主要不良事件相似。最后,当使用带滤网保护装置时,旋切术组中有 11 例(64.7%)患者发生远端大栓子,而 PTA 组中无 1 例(P<0.001)。

结论

旋切术和初次 PTA 的 1 年 TLR 和 TVR 无统计学差异。与初次 PTA 相比,旋切术降低了补救性支架置入的需求。

相似文献

1
Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial.经皮下肢动脉介入治疗中,单纯球囊扩张与 Silverhawk 旋切术联合球囊扩张的随机试验。
J Vasc Interv Radiol. 2011 Sep;22(9):1223-8. doi: 10.1016/j.jvir.2011.05.013. Epub 2011 Jul 14.
2
Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis).随机对照研究:准分子激光斑块消蚀术治疗股腘动脉支架内再狭窄:EXCITE ISR 试验的初步结果(EXCImer 激光随机对照研究治疗股腘动脉支架内再狭窄)。
JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):92-101. doi: 10.1016/j.jcin.2014.09.009. Epub 2014 Dec 10.
3
Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center.SilverHawk斑块旋切术治疗股腘动脉支架内再狭窄的安全性及1年血运重建结局:一项单中心回顾性研究
Cardiovasc Revasc Med. 2012 Jul-Aug;13(4):224-7. doi: 10.1016/j.carrev.2012.03.004. Epub 2012 May 9.
4
Percutaneous lower extremity arterial interventions using primary balloon angioplasty versus cryoplasty: a randomized pilot trial.经皮下肢动脉介入治疗中单纯球囊血管成形术与冷冻球囊血管成形术的比较:一项随机试点试验。
Cardiovasc Revasc Med. 2012 May-Jun;13(3):172-6. doi: 10.1016/j.carrev.2011.12.007.
5
Lesion types and device characteristics that predict distal embolization during percutaneous lower extremity interventions.经皮下肢介入治疗中预测远端栓塞的病变类型和器械特征。
J Vasc Surg. 2011 Feb;53(2):347-52. doi: 10.1016/j.jvs.2010.09.008. Epub 2010 Dec 3.
6
Three-Year Outcomes of Orbital Atherectomy for the Endovascular Treatment of Infrainguinal Claudication or Chronic Limb-Threatening Ischemia.用于血管腔内治疗股腘动脉闭塞症或慢性肢体威胁性缺血的眼眶斑块旋切术的三年疗效
J Endovasc Ther. 2020 Oct;27(5):714-725. doi: 10.1177/1526602820935611. Epub 2020 Jul 3.
7
Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study.应用定向旋切术进行下肢血运重建:DEFINITIVE LE 研究的 12 个月前瞻性结果。
JACC Cardiovasc Interv. 2014 Aug;7(8):923-33. doi: 10.1016/j.jcin.2014.05.006.
8
Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia.血管腔内斑块旋切术治疗严重肢体缺血的胫骨介入治疗中并不优于球囊血管成形术。
J Vasc Surg. 2013 Oct;58(4):941-8. doi: 10.1016/j.jvs.2013.04.024. Epub 2013 Jun 4.
9
Propensity Score-Adjusted Comparison of Long-Term Outcomes Among Revascularization Strategies for Critical Limb Ischemia.经倾向评分调整的临界肢体缺血血运重建策略长期结局比较。
Circ Cardiovasc Interv. 2019 Sep;12(9):e008097. doi: 10.1161/CIRCINTERVENTIONS.119.008097. Epub 2019 Sep 9.
10
Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.药物涂层球囊辅助治疗股总动脉疾病的血管内治疗的疗效和安全性。
Cardiovasc Revasc Med. 2019 Mar;20(3):210-214. doi: 10.1016/j.carrev.2018.06.018. Epub 2018 Jun 25.

引用本文的文献

1
Jetstream Atherectomy with Paclitaxel-Coated Balloons: 3-Year Outcomes of the Prospective Randomized JET-RANGER Study.紫杉醇涂层球囊血管内斑块旋切术:前瞻性随机JET-RANGER研究的3年结果
Int J Angiol. 2024 Oct 3;34(1):56-59. doi: 10.1055/s-0044-1791546. eCollection 2025 Mar.
2
Midterm results of atherectomy as an adjunct to endovascular intervention in a population with chronic limb-threatening ischemia.斑块旋切术作为慢性肢体威胁性缺血患者血管内介入治疗辅助手段的中期结果。
Postepy Kardiol Interwencyjnej. 2024 Sep;20(3):345-352. doi: 10.5114/aic.2024.142494. Epub 2024 Aug 26.
3
Three-Year Safety and Efficacy of Endovascular Treatment of Common Femoral Artery in 150 PAD Patients.
150例下肢动脉硬化闭塞症患者股总动脉血管内治疗的三年安全性和有效性
Biomedicines. 2024 Sep 27;12(10):2213. doi: 10.3390/biomedicines12102213.
4
Atherectomy Plus Balloon Angioplasty for Femoropopliteal Disease Compared to Balloon Angioplasty Alone: A Systematic Review and Meta-analysis.与单纯球囊血管成形术相比,旋切术联合球囊血管成形术治疗股腘动脉疾病:一项系统评价和荟萃分析
J Soc Cardiovasc Angiogr Interv. 2022 Aug 30;1(6):100436. doi: 10.1016/j.jscai.2022.100436. eCollection 2022 Nov-Dec.
5
Femoro-popliteal endovascular interventions.股腘动脉腔内介入治疗
Wideochir Inne Tech Maloinwazyjne. 2024 Jun;19(2):187-197. doi: 10.5114/wiitm.2024.139548. Epub 2024 May 10.
6
Comparison between intermittent claudication chronic limb-threatening ischemia in peripheral arterial disease: a retrospective multicenter cohort study.外周动脉疾病中间歇性跛行与慢性肢体威胁性缺血的比较:一项回顾性多中心队列研究。
Ann Surg Treat Res. 2024 Jun;106(6):344-353. doi: 10.4174/astr.2024.106.6.344. Epub 2024 May 30.
7
Safety and effectiveness of bycross rotational atherectomy and aspiration device: a prospective, multi-center pre-market approval study.旋磨与抽吸装置的安全性和有效性:一项前瞻性、多中心上市前批准研究。
CVIR Endovasc. 2023 Mar 29;6(1):19. doi: 10.1186/s42155-023-00363-0.
8
Jetstream Atherectomy with Paclitaxel-Coated Balloons: Two-Year Outcome of the Prospective Randomized JET-RANGER Study.紫杉醇涂层球囊喷射旋切术:前瞻性随机 JET-RANGER 研究的两年结果。
Vasc Health Risk Manag. 2023 Mar 11;19:133-137. doi: 10.2147/VHRM.S403177. eCollection 2023.
9
Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis.腔内血管重建策略在主髂动脉和股腘动脉疾病中的应用:一项荟萃分析。
Eur Heart J. 2023 Mar 14;44(11):935-950. doi: 10.1093/eurheartj/ehac722.
10
Design of the FP-RESTORE study: a protocol for prospective, observational study of real-world treatments with endovascular therapy in patients with femoropopliteal artery Tosaka III in-stent restenosis.FP-RESTORE 研究设计:一项关于股浅动脉托萨卡 III 型支架内再狭窄患者采用血管内治疗真实世界治疗的前瞻性、观察性研究方案。
BMJ Open. 2022 Dec 6;12(12):e060200. doi: 10.1136/bmjopen-2021-060200.